Thailand Epigenetics Market Size & Outlook, 2023-2030
Thailand epigenetics market, 2018-2030 (US$M)
Related Markets
Thailand epigenetics market highlights
- The Thailand epigenetics market generated a revenue of USD 100.9 million in 2023 and is expected to reach USD 265.9 million by 2030.
- The Thailand market is expected to grow at a CAGR of 14.8% from 2024 to 2030.
- In terms of segment, reagents was the largest revenue generating product in 2023.
- Services is the most lucrative product segment registering the fastest growth during the forecast period.
Epigenetics market data book summary
| Market revenue in 2023 | USD 100.9 million |
| Market revenue in 2030 | USD 265.9 million |
| Growth rate | 14.8% (CAGR from 2023 to 2030) |
| Largest segment | Reagents |
| Fastest growing segment | Services |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Reagents, Kits, Instruments, Enzymes, Services |
| Key market players worldwide | Roche Holding AG, Thermo Fisher Scientific Inc, Eisai Co Ltd, Novartis AG ADR, Element Biosciences, Dovetail Genomics, Illumina Inc, Promega, Abcam PLC |
Other key industry trends
- In terms of revenue, Thailand accounted for 0.7% of the global epigenetics market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, China epigenetics market is projected to lead the regional market in terms of revenue in 2030.
- India is the fastest growing regional market in Asia Pacific and is projected to reach USD 1,635.4 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Epigenetics Market Scope
Epigenetics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Thailand epigenetics market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to epigenetics market will help companies and investors design strategic landscapes.
Reagents was the largest segment with a revenue share of 35.18% in 2023. Horizon Databook has segmented the Thailand epigenetics market based on reagents, kits, instruments, enzymes, services covering the revenue growth of each sub-segment from 2018 to 2030.
The awareness and diagnosis of genetic disorders, particularly Thalassemia and hemoglobinopathy, have increased in Thailand. According to the NCBI article published in January 2022, Thalassemia and hemoglobinopathy stand out as the most prevalent genetic disorders in Thailand, affecting approximately 30% of the population with these conditions.
These blood disorders are rooted in genetic abnormalities that disrupt the body’s regulation of protein (globin) production in red blood cells. This underscores the significance of addressing genetic disorders and the potential demand for advanced medical solutions in Thailand. Furthermore, the epigenetics market in Thailand is expected to witness steady growth over the forecast period.
This can be attributed to the increasing demand for gene-editing technologies and the country’s growing biotechnology industry. In addition, the government’s efforts to promote R&D in biotechnology have contributed to market growth.
Reasons to subscribe to Thailand epigenetics market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Thailand epigenetics market databook
-
Our clientele includes a mix of epigenetics market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Thailand epigenetics market , including forecasts for subscribers. This country databook contains high-level insights into Thailand epigenetics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Thailand epigenetics market size, by product, 2018-2030 (US$M)
Thailand Epigenetics Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
